| | | | |
Securities and Exchange Commission | | 3 | | June 18, 2020 |
2. | Why are the two matters described under “Item 8–Consolidated Statements and Other Financial Information–Legal Proceedings” not included in the “provision for commercial disputes and litigation” or described in Note 23 to your consolidated financial statements? |
Response:
We respectfully acknowledge the Staff’s comment. To assist in the Staff’s understanding of why the two matters that we described in Item 8 are not described in Note 23, we would like to first explain why we decided to describe these two matters in Item 8. We believe that a certain level of consistency between our corporate disclosures in different jurisdictions is desirable, and because these two matters are disclosed in our Japanese annual securities filing, we determined that it would be reasonable to disclose the same legal proceedings in Item 8. In our Japanese annual securities filing, we generally disclose legal proceedings in cases where the potential negative effect on our profits is over ¥5 billion (approximately US$47 million, or approximately 0.3% of our consolidated current assets as of the end of the fiscal year ended March 31, 2019). We also generally disclose legal proceedings for which there is a theoretical risk of criminal liability for the company or its employees, regardless of the financial amounts involved (such as in the case of antitrust matters). Based on these criteria for our Japanese filings, which we maintain in compliance with applicable Japanese disclosure standards, one matter was included in our Japanese annual securities filing for qualitative reasons and the other for quantitative reasons. However, as further described below, both of the matters disclosed in Item 8 involve potential liability that is significantly lower than, for example, the threshold described in the instructions to Item 103 of Regulation S-K, which permits the application of a quantitative threshold of “10 percent of the current assets of the registrant” in order to determine whether a proceeding should be disclosed.
The EC Matter
The matter pending in the European Court of Justice (the “EC Matter”) is regarding our appeal filed in May 2018 with the European Court of Justice regarding a portion of the fines that were ordered upon our then subsidiary, TOKIN Corporation, and NEC Corporation relating to cartel activity by TOKIN Corporation regarding certain types of electrolytic capacitors. Of the total of €16.4 million in fines, €8.8 million was to be payable by TOKIN Corporation, €5.0 million was to be payable jointly and severally by TOKIN Corporation and NEC Corporation (as the parent of the wrongful actor), and the remaining €2.6 million was to be payable by NEC Corporation (as a “repeat offender” penalty as described below).
In April 2017, the Company completed the sale of all of its shares of TOKIN Corporation to a third-party acquiror, and the only obligation for which the Company is ultimately responsible after such sale is the €2.6 million portion, with the remainder of the fine being the responsibility of TOKIN Corporation. This €2.6 million fine ordered upon the Company primarily represents a “repeat offender” penalty due to our involvement in a prior unrelated cartel-related matter involving DRAM products for which a penalty was imposed by the European Commission over ten years ago.
We note that we stated in our response to comment 3 in our letter filed via EDGAR on June 9, 2020 that the “provision for commercial disputes and litigation” does not include any amounts with respect to the EC Matter. While this was true for most of the €16.4 million fine, we inadvertently neglected to mention that the €2.6 million “repeat offender” portion of the fines is indeed included in the “provision for commercial disputes and litigation.” We are in the process of appealing this €2.6 million fine based primarily on an argument that the repeat offender penalty should not be applicable as the wrongdoing in the EC Matter was by TOKIN Corporation and not the Company, but have included the amount in the “provision for commercial disputes and litigation” based on our assessment of the risk of our appeal being unsuccessful. However, we do not describe the EC Matter in Note 23 due to its immateriality in terms of the amounts involved and its potential non-monetary impacts on our business pursuant to IAS 1.31. Furthermore, we do not believe that we would have decided to describe the EC Matter in Item 8 if it were not for its inclusion in our Japanese annual securities filing.